Charles Joly Beauparlant

CHARLES JOLY BEAUPARLANT

Ph.D Molecular Medicine


CAREER SUMMARY

The principal theme of my academic research is genetics and genomics. I completed my Master’s degree on the genetic risk factor of breast cancer in high risk family. Before starting my PhD, I received a Certificate in informatic.

The main goal of my research is to develop new tools to help with the analysis of epigenomic data. I especially interested in the analysis of transcription factors enrichment profiles. I’m trying to find new ways to compare profiles that are efficient and robust to facilitate the study of the dynamic of transcription factors recruitment.

During my PhD, I also had the opportunity to work in transcriptomic (RNA-Seq), metagenomics and exome sequencing.

I also teach the Computational Genomics (BIF-4004/BIF-7004) course and the sections on Next-Generation Sequencing, Epigenomics and Transcriptomics in the Bioinformatic I course (BIF-7900).

 

FUNDING

2013-2016 Doctoral Award – FRQS
2012-2013 Doctoral Award – CREMOGH
2008-2009 Master Degree Award – IRSC
2007-2008 Genomic Formation Award – IRSC

 

PUBLICATIONS

  • Le Luyer J., Deschamps M-H., Proulx E., Poirier Stewart N., Joly Beauparlant
    C., Droit A., Robert C., Vandenberg G. W. Establishment of a comprehensive
    reference transcriptome for vertebral bone tissue to study the impacts of
    nutritional phosphorus deficiency in rainbow trout (Oncorhynchus mykiss,
    Walbaum), Marine genomics 2014, accepted.
  • Fournier F, Beauparlant CJ, Paradis R, Droit A. rTANDEM, an R/Bioconductor
    package for MS/MS protein identification. Bioinformatics 2014, btu178.
  • Bélanger S, Plourde KV, Beauparlant CJ, St-Laurent Pedneault C, Bouffard F,
    Ouellette G, Labrie Y, Durocher F. Impaired Effects of a FANCC Splicing
    Isoform in FANC-BRCA DNA Repair Pathway. J Genet Syndr Gene Ther 2013;4:5.
  • Markovitz AN, Beauparlant CJ, Toupin D, Wang S, Droit A, Gevry N. NGS++:
    a library for rapid prototyping of epigenomics software tools. Bioinformatics
    2013;29(15):1893-4.
  • Desjardins S, Beauparlant JC, Labrie Y, Ouellette G, Durocher F. Variations in
    the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian
    families with high risk of breast cancer. BMC Cancer 2009;9:181.
  • Guénard F, Labrie Y, Ouellette G, Beauparlant CJ, Durocher F. Genetic sequence
    variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French
    Canadian families with high risk of breast cancer. J. Hum. Genet 2009
    Mar;54(3):152-161.
  • Guénard F, Labrie Y, Ouellette G, Joly Beauparlant C, Simard J, Durocher F.
    Mutational analysis of the breast cancer susceptibility gene BRIP1
    /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families. J. Hum. Genet
    2008;53(7):579-591.
  • Guénard F, Labrie Y, Ouellette G, Beauparlant CJ, Bessette P, Chiquette J,
    Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M, Durocher F.
    Germline mutations in the breast cancer susceptibility gene PTEN are rare in
    high-risk non-BRCA1/2 French Canadian breast cancer families. Fam. Cancer
    2007;6(4):483-490.

 

FORMATION

2012- PhD bio-informatique
Université Laval, Québec
Director: Arnaud Droit
Codirector: Jacques Corbeil
Thesis title: Development of new tools for next-generation sequencing applied
to ChIP-Seq and microbiome

2011-2012 Informatic certificate.
Université Laval, Québec

2008-2011 Master degree in Physiologie-Endocrinologie
Université Laval, Québec
Director: Francine Durocher
FÉS roll of honor.
Subject: Breast cancer genetic susceptibility.

2008-2009 Microprogram in Génomique Fonctionnelle
Université Laval, Québec

2004-2007 Baccalaureate in Biotechnology
Concentration in Molecular Biology
Université de Sherbrooke, Sherbrooke

2001-2004 Techniques in Chemistry-Biology
Cégep de Lévis-Lauzon, Lévis